Assyro AI

FDA Orange Book · active-ingredient family

Sodium monofluorophosphate

Sodium monofluorophosphate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:EXTRA-STRENGTH AIM · NDA 019518

1

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · gel, paste

ProductApplicantApplicationTEApproved
EXTRA-STRENGTH AIM×2CHESEBROUGH PONDSNDA 019518Aug 06, 1986

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sodium monofluorophosphate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.